- Ongoing, recruitingPhase I and Phase II (Integrated)- Other
Phase-I/II trial for relapsed or refractory AML patients combining cytarabine and mitoxantrone with venetoclax (TUD-RELAX1-070)
This study is for adults with a type of blood cancer called AML that has come back or not responded to usual treatments. It's testing a new combination of medicines to see if it's safe and helps more people. It combines standard chemotherapy drugs with a newer drug called venetoclax.
Germany - RecruitingPHASE3
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
This study looks at new ways to treat children with a type of blood cancer called Acute Myeloid Leukaemia (AML). It compares different chemotherapy drugs, including a drug called gemtuzumab ozogamicin, and different types of stem cell transplants to find the most effective and safest treatments for young patients.
For: Acute Myeloid LeukaemiaAustralia · France · Ireland